The effect of ranibizumab versus photodynamic therapy on DNA damage in patients with exudative macular degeneration

Molecular Vision

Volumn 15, Issue , 2009, Pages 1194-1199

  Mozaffarieh, M ^a   Schotzau A ^a   Josifova, T ^a   Flammer, Josef ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; SINGLE STRANDED DNA; VERTEPORFIN;

AGED; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DNA FRAGMENTATION; DNA TRANSFER; ELECTRIC FIELD; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKOCYTE; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; SIDE EFFECT; SINGLE STRANDED DNA BREAK; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTIBODIES, MONOCLONAL; COMET ASSAY; DATA INTERPRETATION, STATISTICAL; DNA BREAKS, SINGLE-STRANDED; FEMALE; HUMANS; LEUKOCYTES; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PORPHYRINS;

EID: 67650081395     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya'ale D, Negrel AD, Resnikoff S. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 2004; 11:67-115.
2. Evans JR, Fletcher AE, Wormald RP. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology 2004; 111:513-7.
3. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122:564-72.
4. Dunaief JL. Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. Invest Ophthalmol Vis Sci 2006; 47:4660-4.
5. Kasahara E, Lin LR, Ho YS, Reddy VN. SOD2 protects against oxidation-induced apoptosis in mouse retinal pigment epithelium: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci 2005; 46:3426-34.
6. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 2003; 76:397-403.
7. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 1991; 91:14S-22S.
8. Katyal S, McKinnon PJ. DNA strand breaks, neurodegeneration and aging in the brain. Mech Ageing Dev 2008; 129:483-91.
9. Rothkamm K, Gunasekara K, Warda SA, Krempler A, Lobrich M. Radiation-induced HPRT mutations resulting from misrejoined DNA double-strand breaks. Radiat Res 2008; 169:639-48.
10. Seo KY, Jelinsky SA, Loechler EL. Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens. Mutat Res 2000; 463:215-46.
11. Simone S, Gorin Y, Velagapudi C, Abboud HE, Habib SL. Mechanism of Oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2′-deoxyguanosine-DNA glycosylase. Diabetes 2008; 57:2626-36.
12. Moenkemann H, Flammer J, Wunderlich K, Breipohl W, Schild HH, Golubnitschaja O. Increased DNA breaks and up-regulation of both G(1) and G(2) checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in circulating leukocytes of glaucoma patients and vasospastic individuals. Amino Acids 2005; 28:199-205.
13. Mozaffarieh M, Schoetzau A, Sauter M, Grieshaber M, Orgul S, Golubnitschaja O, Flammer J. Comet assay analysis of single-stranded DNA breaks in circulating leukocytes of glaucoma patients. Mol Vis 2008; 14:1584-8.
14. van den Bergh H. Photodynamic therapy of age-related macular degeneration: History and principles. Semin Ophthalmol 2001; 16:181-200.
15. Dhawan A, Bajpayee M, Parmar D. Comet assay: a reliable tool for the assessment of DNA damage in different models. Cell Biol Toxicol 2009; 25:5-32.
16. Hofer T, Karlsson HL, Moller L. DNA oxidative damage and strand breaks in young healthy individuals: a gender difference and the role of life style factors. Free Radic Res 2006; 40:707-14.
17. Liu Y, Li CM, Lu Z, Ding S, Yang X, Mo J. Studies on formation and repair of formaldehyde-damaged DNA by detection of DNA-protein crosslinks and DNA breaks. Front Biosci 2006; 11:991-7.
18. Panayiotidis MI, Rancourt RC, Allen CB, Riddle SR, Schneider BK, Ahmad S, White CW. Hyperoxia-induced DNA damage causes decreased DNA methylation in human lung epithelial-like A549 cells. Antioxid Redox Signal 2004; 6:129-36.
19. Peng T, Shen HM, Liu ZM, Yan LN, Peng MH, Li LQ, Liang RX, Wei ZL, Halliwell B, Ong CN. Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China. World J Gastroenterol 2003; 9:2186-93.
20. Hengstler JG, Bolm-Audorff U, Faldum A, Janssen K, Reifenrath M, Gotte W, Jung D, Mayer-Popken O, Fuchs J, Gebhard S, Bienfait HG, Schlink K, Dietrich C, Faust D, Epe B, Oesch F. Occupational exposure to heavy metals: DNA damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as more dangerous than hitherto expected. Carcinogenesis 2003; 24:63-73.
21. Meyers CD, Fairbairn DW, O'Neill KL. Measuring the repair of H2O2-induced DNA single strand breaks using the single cell gel assay. Cytobios 1993; 74:147-53.
22. Kleiman NJ, Wang RR, Spector A. Ultraviolet light induced DNA damage and repair in bovine lens epithelial cells. Curr Eye Res 1990; 9:1185-93.
23. Clo E, Snyder JW, Voigt NV, Ogilby PR, Gothelf KV. DNA-programmed control of photosensitized singlet oxygen production. J Am Chem Soc 2006; 128:4200-1.
24. Tsay JM, Trzoss M, Shi L, Kong X, Selke M, Jung ME, Weiss S. Singlet oxygen production by Peptide-coated quantum dot-photosensitizer conjugates. J Am Chem Soc 2007; 129:6865-71.
25. Stief TW. The physiology and pharmacology of singlet oxygen. Med Hypotheses 2003; 60:567-72.
26. Boveris A. Biochemistry of free radicals: from electrons to tissues. Medicina (B Aires) 1998; 58:350-6.
27. Michaeli A, Feitelson J. Reactivity of singlet oxygen toward amino acids and peptides. Photochem Photobiol 1994; 59:284-9.
28. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45:115-34.
29. Tuo J, Ning B, Bojanowski CM, Lin ZN, Ross RJ, Reed GF, Shen D, Jiao X, Zhou M, Chew EY, Kadlubar FF, Chan CC. Synergic effect of polymorphisms in ERCC6 5′ flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci USA 2006; 103:9256-61.
30. Darley-Usmar V, Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996; 13:649-62.
31. Baker MA, He SQ. Elaboration of cellular DNA breaks by hydroperoxides. Free Radic Biol Med 1991; 11:563-72.
32. Sandstrom BE. Induction and rejoining of DNA single-strand breaks in relation to cellular growth in human cells exposed to three hydroperoxides at 0 degrees C and 37 degrees C. Free Radic Res Commun 1991; 15:79-89.
33. Eibenschutz L, Marenda S, Buccini P, De SP, Ferrari A, Mariani G, Silipo V, Catricala C. Giant and large basal cell carcinoma treated with topical photodynamic therapy. Eur J Dermatol 2008; 18:663-6.
34. Stephan H, Boeloeni R, Eggert A, Bornfeld N, Schueler A. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines. Invest Ophthalmol Vis Sci 2008; 49:3158-63.
35. Silva JN, Filipe P, Morliere P, Maziere JC, Freitas JP, Gomes MM, Santus R. Photodynamic therapy: Dermatology and ophthalmology as main fields of current applications in clinic. Biomed Mater Eng 2008; 18:319-27.
36. Szeimies RM, Matheson RT, Davis SA, Bhatia AC, Frambach Y, Klovekorn W, Fesq H, Berking C, Reifenberger J, Thaci D. Topical Methyl Aminolevulinate Photodynamic Therapy Using Red Light-Emitting Diode Light for Multiple Actinic Keratoses: A Randomized Study. Dermatol Surg 2009; 35:586-92.
37. Calista D. Photodynamic therapy for the treatment of a giant superficial basal cell carcinoma. Photodermatol Photoimmunol Photomed 2009; 25:53-4.
38. Alster TS, Surin-Lord SS. Photodynamic therapy: practical cosmetic applications. J Drugs Dermatol 2006; 5:764-8.
39. Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 2005; 46:726-33.
40. Vedula SS, Krzystolik MG. Antiangiogenic therapy with antivascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2008:CD005139.
41. Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, Schneider S, Acharya NR. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 2007; 144:850-7.